Search results
Results from the WOW.Com Content Network
The Health Products Regulatory Authority (HPRA; Irish: An tÚdarás Rialála Táirgí Sláinte) is an Irish regulatory agency. It advises the Irish government. It is responsible for both public and animal health. It regulates medicines, medical devices, clinical trials and other health products and monitors the safety of cosmetics.
State Agencies or Non-Commercial State Agencies in Ireland are public sector bodies of the state that have a statutory obligation to perform specific tasks on behalf of the Government of Ireland. Such agencies are considered "arm's length" bodies as they are largely isolated from the workings of central government .
A stringent regulatory authority is a regulatory authority which is: a) a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), being the European Commission, the US Food and Drug Administration and the Ministry of Health, Labour and Welfare of Japan also represented by the Pharmaceuticals and Medical Devices Agency (as before ...
This page was last edited on 11 December 2021, at 02:38 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Members of the High-Level Task Force on COVID-19 Vaccination are made up of senior representatives from the Department of Health, the Health Service Executive, the Health Products Regulatory Authority, the Office of the Government Chief Information Officer, the Office of Government Procurement, IDA Ireland, the Dublin Airport Authority, the ...
Vhi Healthcare (which is a semi-state company), Laya Healthcare, and Irish Life Health provide health insurance, among other services. On 2 July 2012, GloHealth entered the market to become Ireland's fourth private health insurer. In 2005, 47.6% of people were covered by private health insurance.
The Department of Health (Irish: An Roinn Sláinte) is a department of the Government of Ireland.The department's mission is to "support, protect and empower individuals, families and their communities to achieve their full health potential by putting health at the centre of public policy and by leading the development of high quality, equitable and efficient health and personal social services."
The MHRA and the US Food and Drug Administration were criticised in the 2012 book Bad Pharma, [43] and in 2004 by David Healy in evidence to the House of Commons Health Committee, [44] for having undergone regulatory capture, i.e. advancing the interests of the drug companies rather than the interests of the public.